Expert Interview
Discussing the potential of Sanofi/Regeneron FDA approved therapy, Kevzara (sarilumab), in Polymyalgia rheumatica (PMR)
Ticker(s): SNY, REGNA rheumatologist with experience in treating Polymyalgia rheumatica
Can you please tell us more about Polymyalgia rheumatica and how it affects patients?
What are the current treatment options for Polymyalgia rheumatica and how effective are they?
How does Kevzara differ from existing treatments for Polymyalgia rheumatica?
What is the mechanism of action for Kevzara and how does it work to treat Polymyalgia rheumatica?
Could you talk about the results of the clinical trials for Kevzara in treating Polymyalgia rheumatica, and how they supported approval?
How often do patients need to receive Kevzara injections and for how long?
How much does Kevzara cost, factoring insurance coverage?
How does Kevzara compare to other drugs in its class for treating autoimmune disorders?
Added By: slingshot_insightsAre there any long-term risks associated with Kevzara treatment?
How does Kevzara fit into the overall treatment landscape for autoimmune disorders?
Added By: slingshot_insightsAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
